NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
42 hedge funds and large institutions have $29.4M invested in InVivo Therapeutics Holdings Corp in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
75% less call options, than puts
Call options by funds: $42K | Put options by funds: $170K
Holders
42
Holding in Top 10
1
Calls
$42K
Puts
$170K
Top Buyers
| 1 | +$7.92M | |
| 2 | +$154K | |
| 3 | +$150K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$147K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$73.5K |
Top Sellers
| 1 | -$839K | |
| 2 | -$379K | |
| 3 | -$336K | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$228K |
| 5 |
Goldman Sachs
New York
|
-$139K |